nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Doxapram—Fosphenytoin—epilepsy syndrome	0.148	0.593	CrCrCtD
Darifenacin—CHRM3—epilepsy syndrome	0.127	0.329	CbGaD
Darifenacin—CHRM1—epilepsy syndrome	0.118	0.307	CbGaD
Darifenacin—Doxapram—Phenytoin—epilepsy syndrome	0.102	0.407	CrCrCtD
Darifenacin—CHRM2—epilepsy syndrome	0.0965	0.25	CbGaD
Darifenacin—CYP2D6—epilepsy syndrome	0.0441	0.115	CbGaD
Darifenacin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0131	0.0819	CbGbCtD
Darifenacin—CYP3A4—Trimethadione—epilepsy syndrome	0.0122	0.0762	CbGbCtD
Darifenacin—CYP3A4—Felbamate—epilepsy syndrome	0.0122	0.0762	CbGbCtD
Darifenacin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0115	0.0716	CbGbCtD
Darifenacin—CYP2D6—Propofol—epilepsy syndrome	0.0109	0.0677	CbGbCtD
Darifenacin—CYP3A4—Clonazepam—epilepsy syndrome	0.0104	0.0647	CbGbCtD
Darifenacin—CYP3A4—Clobazam—epilepsy syndrome	0.00996	0.0621	CbGbCtD
Darifenacin—CYP3A4—Rufinamide—epilepsy syndrome	0.00847	0.0528	CbGbCtD
Darifenacin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00825	0.0514	CbGbCtD
Darifenacin—CYP3A4—Primidone—epilepsy syndrome	0.0077	0.048	CbGbCtD
Darifenacin—CYP3A4—Phenytoin—epilepsy syndrome	0.0074	0.0461	CbGbCtD
Darifenacin—CYP3A4—Propofol—epilepsy syndrome	0.0069	0.043	CbGbCtD
Darifenacin—CYP3A4—Acetazolamide—epilepsy syndrome	0.0066	0.0411	CbGbCtD
Darifenacin—CYP3A4—Phenobarbital—epilepsy syndrome	0.0066	0.0411	CbGbCtD
Darifenacin—CYP3A4—Midazolam—epilepsy syndrome	0.0065	0.0405	CbGbCtD
Darifenacin—CYP3A4—Diazepam—epilepsy syndrome	0.00625	0.039	CbGbCtD
Darifenacin—CYP3A4—Zonisamide—epilepsy syndrome	0.0061	0.038	CbGbCtD
Darifenacin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00493	0.0307	CbGbCtD
Darifenacin—CYP3A4—Topiramate—epilepsy syndrome	0.00445	0.0277	CbGbCtD
Darifenacin—Doxapram—KCNK3—epilepsy syndrome	0.000513	0.119	CrCbGaD
Darifenacin—Doxapram—KCNK9—epilepsy syndrome	0.000513	0.119	CrCbGaD
Darifenacin—CHRM4—head—epilepsy syndrome	0.000306	0.05	CbGeAlD
Darifenacin—CHRM4—nervous system—epilepsy syndrome	0.00029	0.0474	CbGeAlD
Darifenacin—CHRM2—forebrain—epilepsy syndrome	0.000287	0.0468	CbGeAlD
Darifenacin—CHRM4—central nervous system—epilepsy syndrome	0.000279	0.0456	CbGeAlD
Darifenacin—CHRM2—telencephalon—epilepsy syndrome	0.000264	0.0431	CbGeAlD
Darifenacin—CHRM1—forebrain—epilepsy syndrome	0.000261	0.0426	CbGeAlD
Darifenacin—CHRM1—telencephalon—epilepsy syndrome	0.00024	0.0392	CbGeAlD
Darifenacin—CHRM5—head—epilepsy syndrome	0.000239	0.0391	CbGeAlD
Darifenacin—CHRM3—forebrain—epilepsy syndrome	0.000234	0.0382	CbGeAlD
Darifenacin—CYP2D6—hindbrain—epilepsy syndrome	0.000228	0.0373	CbGeAlD
Darifenacin—CHRM5—nervous system—epilepsy syndrome	0.000227	0.037	CbGeAlD
Darifenacin—CHRM4—brain—epilepsy syndrome	0.000222	0.0362	CbGeAlD
Darifenacin—CHRM5—central nervous system—epilepsy syndrome	0.000218	0.0357	CbGeAlD
Darifenacin—CHRM3—telencephalon—epilepsy syndrome	0.000215	0.0351	CbGeAlD
Darifenacin—Difenoxin—OPRM1—epilepsy syndrome	0.000185	0.0429	CrCbGaD
Darifenacin—Loperamide—CACNA1A—epilepsy syndrome	0.000181	0.042	CrCbGaD
Darifenacin—Anileridine—OPRM1—epilepsy syndrome	0.00018	0.0418	CrCbGaD
Darifenacin—CHRM5—brain—epilepsy syndrome	0.000173	0.0283	CbGeAlD
Darifenacin—Diphenoxylate—OPRD1—epilepsy syndrome	0.00017	0.0395	CrCbGaD
Darifenacin—CHRM2—head—epilepsy syndrome	0.000164	0.0268	CbGeAlD
Darifenacin—CHRM2—nervous system—epilepsy syndrome	0.000156	0.0254	CbGeAlD
Darifenacin—CHRM2—central nervous system—epilepsy syndrome	0.00015	0.0245	CbGeAlD
Darifenacin—CHRM1—head—epilepsy syndrome	0.000149	0.0244	CbGeAlD
Darifenacin—CHRM1—nervous system—epilepsy syndrome	0.000142	0.0231	CbGeAlD
Darifenacin—Clidinium—CHRM3—epilepsy syndrome	0.000139	0.0322	CrCbGaD
Darifenacin—CHRM1—central nervous system—epilepsy syndrome	0.000136	0.0223	CbGeAlD
Darifenacin—CHRM3—head—epilepsy syndrome	0.000134	0.0218	CbGeAlD
Darifenacin—Trospium—CHRM3—epilepsy syndrome	0.000134	0.031	CrCbGaD
Darifenacin—Fexofenadine—SLCO1A2—epilepsy syndrome	0.000133	0.0309	CrCbGaD
Darifenacin—CYP2D6—brainstem—epilepsy syndrome	0.000131	0.0214	CbGeAlD
Darifenacin—Diphenoxylate—OPRM1—epilepsy syndrome	0.00013	0.0302	CrCbGaD
Darifenacin—Clidinium—CHRM1—epilepsy syndrome	0.00013	0.03	CrCbGaD
Darifenacin—CHRM3—nervous system—epilepsy syndrome	0.000127	0.0207	CbGeAlD
Darifenacin—CYP2D6—forebrain—epilepsy syndrome	0.000126	0.0206	CbGeAlD
Darifenacin—Loperamide—POMC—epilepsy syndrome	0.000125	0.0291	CrCbGaD
Darifenacin—Trospium—CHRM1—epilepsy syndrome	0.000125	0.0289	CrCbGaD
Darifenacin—CHRM3—central nervous system—epilepsy syndrome	0.000122	0.0199	CbGeAlD
Darifenacin—CHRM2—brain—epilepsy syndrome	0.000119	0.0194	CbGeAlD
Darifenacin—Isopropamide—CHRM3—epilepsy syndrome	0.000118	0.0274	CrCbGaD
Darifenacin—CYP2D6—telencephalon—epilepsy syndrome	0.000116	0.019	CbGeAlD
Darifenacin—Mepenzolate—CHRM3—epilepsy syndrome	0.000112	0.0259	CrCbGaD
Darifenacin—Isopropamide—CHRM1—epilepsy syndrome	0.00011	0.0255	CrCbGaD
Darifenacin—CHRM1—brain—epilepsy syndrome	0.000108	0.0177	CbGeAlD
Darifenacin—Mepenzolate—CHRM1—epilepsy syndrome	0.000104	0.0241	CrCbGaD
Darifenacin—Trospium—CHRM2—epilepsy syndrome	0.000102	0.0236	CrCbGaD
Darifenacin—Diphenidol—CHRM3—epilepsy syndrome	9.78e-05	0.0227	CrCbGaD
Darifenacin—CHRM3—brain—epilepsy syndrome	9.69e-05	0.0158	CbGeAlD
Darifenacin—Diphenidol—CHRM1—epilepsy syndrome	9.12e-05	0.0212	CrCbGaD
Darifenacin—Clotrimazole—CYP11A1—epilepsy syndrome	8.98e-05	0.0208	CrCbGaD
Darifenacin—Mepenzolate—CHRM2—epilepsy syndrome	8.5e-05	0.0197	CrCbGaD
Darifenacin—Diphenidol—CHRM2—epilepsy syndrome	7.45e-05	0.0173	CrCbGaD
Darifenacin—Fentanyl—OPRD1—epilepsy syndrome	7.33e-05	0.017	CrCbGaD
Darifenacin—CYP2D6—head—epilepsy syndrome	7.23e-05	0.0118	CbGeAlD
Darifenacin—Loperamide—OPRD1—epilepsy syndrome	7.06e-05	0.0164	CrCbGaD
Darifenacin—CYP3A4—nervous system—epilepsy syndrome	6.97e-05	0.0114	CbGeAlD
Darifenacin—CYP2D6—nervous system—epilepsy syndrome	6.86e-05	0.0112	CbGeAlD
Darifenacin—CYP3A4—central nervous system—epilepsy syndrome	6.71e-05	0.011	CbGeAlD
Darifenacin—CYP2D6—central nervous system—epilepsy syndrome	6.6e-05	0.0108	CbGeAlD
Darifenacin—CYP2D6—cerebellum—epilepsy syndrome	6.45e-05	0.0105	CbGeAlD
Darifenacin—Headache—Levetiracetam—epilepsy syndrome	5.79e-05	0.000449	CcSEcCtD
Darifenacin—Angioedema—Pregabalin—epilepsy syndrome	5.76e-05	0.000447	CcSEcCtD
Darifenacin—Hypersensitivity—Clonazepam—epilepsy syndrome	5.76e-05	0.000447	CcSEcCtD
Darifenacin—Dizziness—Vigabatrin—epilepsy syndrome	5.75e-05	0.000446	CcSEcCtD
Darifenacin—Confusional state—Valproic Acid—epilepsy syndrome	5.74e-05	0.000445	CcSEcCtD
Darifenacin—Pruritus—Zonisamide—epilepsy syndrome	5.74e-05	0.000445	CcSEcCtD
Darifenacin—Hypersensitivity—Phenytoin—epilepsy syndrome	5.72e-05	0.000444	CcSEcCtD
Darifenacin—Flatulence—Gabapentin—epilepsy syndrome	5.7e-05	0.000442	CcSEcCtD
Darifenacin—Oedema—Valproic Acid—epilepsy syndrome	5.69e-05	0.000442	CcSEcCtD
Darifenacin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.69e-05	0.000442	CcSEcCtD
Darifenacin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.69e-05	0.000442	CcSEcCtD
Darifenacin—Nausea—Propofol—epilepsy syndrome	5.68e-05	0.000441	CcSEcCtD
Darifenacin—Vomiting—Fosphenytoin—epilepsy syndrome	5.67e-05	0.00044	CcSEcCtD
Darifenacin—Diarrhoea—Felbamate—epilepsy syndrome	5.67e-05	0.00044	CcSEcCtD
Darifenacin—Abdominal pain—Lamotrigine—epilepsy syndrome	5.66e-05	0.000439	CcSEcCtD
Darifenacin—Dysgeusia—Gabapentin—epilepsy syndrome	5.66e-05	0.000439	CcSEcCtD
Darifenacin—Dizziness—Diazepam—epilepsy syndrome	5.66e-05	0.000439	CcSEcCtD
Darifenacin—Infection—Valproic Acid—epilepsy syndrome	5.65e-05	0.000439	CcSEcCtD
Darifenacin—Syncope—Pregabalin—epilepsy syndrome	5.65e-05	0.000439	CcSEcCtD
Darifenacin—Rash—Fosphenytoin—epilepsy syndrome	5.62e-05	0.000437	CcSEcCtD
Darifenacin—Dermatitis—Fosphenytoin—epilepsy syndrome	5.62e-05	0.000436	CcSEcCtD
Darifenacin—Fentanyl—OPRM1—epilepsy syndrome	5.61e-05	0.013	CrCbGaD
Darifenacin—Asthenia—Clonazepam—epilepsy syndrome	5.61e-05	0.000435	CcSEcCtD
Darifenacin—Rhinitis—Topiramate—epilepsy syndrome	5.6e-05	0.000435	CcSEcCtD
Darifenacin—Back pain—Gabapentin—epilepsy syndrome	5.59e-05	0.000434	CcSEcCtD
Darifenacin—Headache—Fosphenytoin—epilepsy syndrome	5.59e-05	0.000434	CcSEcCtD
Darifenacin—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.58e-05	0.000433	CcSEcCtD
Darifenacin—Palpitations—Pregabalin—epilepsy syndrome	5.57e-05	0.000432	CcSEcCtD
Darifenacin—Asthenia—Phenytoin—epilepsy syndrome	5.57e-05	0.000432	CcSEcCtD
Darifenacin—Nausea—Midazolam—epilepsy syndrome	5.56e-05	0.000431	CcSEcCtD
Darifenacin—Hallucination—Topiramate—epilepsy syndrome	5.56e-05	0.000431	CcSEcCtD
Darifenacin—Tachycardia—Valproic Acid—epilepsy syndrome	5.55e-05	0.000431	CcSEcCtD
Darifenacin—Diarrhoea—Zonisamide—epilepsy syndrome	5.55e-05	0.000431	CcSEcCtD
Darifenacin—Pharyngitis—Topiramate—epilepsy syndrome	5.55e-05	0.00043	CcSEcCtD
Darifenacin—Loss of consciousness—Pregabalin—epilepsy syndrome	5.54e-05	0.00043	CcSEcCtD
Darifenacin—Asthenia—Oxcarbazepine—epilepsy syndrome	5.54e-05	0.00043	CcSEcCtD
Darifenacin—Pruritus—Clonazepam—epilepsy syndrome	5.53e-05	0.000429	CcSEcCtD
Darifenacin—Vomiting—Vigabatrin—epilepsy syndrome	5.53e-05	0.000429	CcSEcCtD
Darifenacin—Skin disorder—Valproic Acid—epilepsy syndrome	5.53e-05	0.000429	CcSEcCtD
Darifenacin—Urinary tract disorder—Topiramate—epilepsy syndrome	5.52e-05	0.000428	CcSEcCtD
Darifenacin—Oedema peripheral—Topiramate—epilepsy syndrome	5.5e-05	0.000427	CcSEcCtD
Darifenacin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.5e-05	0.000427	CcSEcCtD
Darifenacin—Cough—Pregabalin—epilepsy syndrome	5.5e-05	0.000427	CcSEcCtD
Darifenacin—Pruritus—Phenytoin—epilepsy syndrome	5.49e-05	0.000426	CcSEcCtD
Darifenacin—Nausea—Levetiracetam—epilepsy syndrome	5.49e-05	0.000426	CcSEcCtD
Darifenacin—Rash—Vigabatrin—epilepsy syndrome	5.48e-05	0.000426	CcSEcCtD
Darifenacin—Dizziness—Felbamate—epilepsy syndrome	5.48e-05	0.000425	CcSEcCtD
Darifenacin—Dermatitis—Vigabatrin—epilepsy syndrome	5.48e-05	0.000425	CcSEcCtD
Darifenacin—Urethral disorder—Topiramate—epilepsy syndrome	5.48e-05	0.000425	CcSEcCtD
Darifenacin—Pruritus—Oxcarbazepine—epilepsy syndrome	5.46e-05	0.000424	CcSEcCtD
Darifenacin—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.46e-05	0.000424	CcSEcCtD
Darifenacin—Vision blurred—Gabapentin—epilepsy syndrome	5.45e-05	0.000423	CcSEcCtD
Darifenacin—Headache—Vigabatrin—epilepsy syndrome	5.45e-05	0.000423	CcSEcCtD
Darifenacin—Hypertension—Pregabalin—epilepsy syndrome	5.44e-05	0.000422	CcSEcCtD
Darifenacin—Vomiting—Diazepam—epilepsy syndrome	5.44e-05	0.000422	CcSEcCtD
Darifenacin—Loperamide—OPRM1—epilepsy syndrome	5.41e-05	0.0125	CrCbGaD
Darifenacin—Rash—Diazepam—epilepsy syndrome	5.4e-05	0.000419	CcSEcCtD
Darifenacin—Dermatitis—Diazepam—epilepsy syndrome	5.39e-05	0.000419	CcSEcCtD
Darifenacin—Visual impairment—Topiramate—epilepsy syndrome	5.38e-05	0.000418	CcSEcCtD
Darifenacin—Arthralgia—Pregabalin—epilepsy syndrome	5.37e-05	0.000417	CcSEcCtD
Darifenacin—Dizziness—Zonisamide—epilepsy syndrome	5.36e-05	0.000416	CcSEcCtD
Darifenacin—Headache—Diazepam—epilepsy syndrome	5.36e-05	0.000416	CcSEcCtD
Darifenacin—Diarrhoea—Clonazepam—epilepsy syndrome	5.35e-05	0.000415	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.33e-05	0.000414	CcSEcCtD
Darifenacin—Asthenia—Carbamazepine—epilepsy syndrome	5.32e-05	0.000413	CcSEcCtD
Darifenacin—Diarrhoea—Phenytoin—epilepsy syndrome	5.31e-05	0.000412	CcSEcCtD
Darifenacin—Nausea—Fosphenytoin—epilepsy syndrome	5.3e-05	0.000411	CcSEcCtD
Darifenacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.28e-05	0.00041	CcSEcCtD
Darifenacin—Erythema multiforme—Topiramate—epilepsy syndrome	5.28e-05	0.00041	CcSEcCtD
Darifenacin—Angioedema—Gabapentin—epilepsy syndrome	5.28e-05	0.00041	CcSEcCtD
Darifenacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.28e-05	0.00041	CcSEcCtD
Darifenacin—Vomiting—Felbamate—epilepsy syndrome	5.27e-05	0.000409	CcSEcCtD
Darifenacin—Dry mouth—Pregabalin—epilepsy syndrome	5.25e-05	0.000407	CcSEcCtD
Darifenacin—Pruritus—Carbamazepine—epilepsy syndrome	5.24e-05	0.000407	CcSEcCtD
Darifenacin—CYP2D6—brain—epilepsy syndrome	5.24e-05	0.00856	CbGeAlD
Darifenacin—Rash—Felbamate—epilepsy syndrome	5.22e-05	0.000405	CcSEcCtD
Darifenacin—Eye disorder—Topiramate—epilepsy syndrome	5.22e-05	0.000405	CcSEcCtD
Darifenacin—Dermatitis—Felbamate—epilepsy syndrome	5.22e-05	0.000405	CcSEcCtD
Darifenacin—Headache—Felbamate—epilepsy syndrome	5.19e-05	0.000403	CcSEcCtD
Darifenacin—Confusional state—Pregabalin—epilepsy syndrome	5.19e-05	0.000403	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.19e-05	0.000402	CcSEcCtD
Darifenacin—Syncope—Gabapentin—epilepsy syndrome	5.18e-05	0.000402	CcSEcCtD
Darifenacin—Dizziness—Clonazepam—epilepsy syndrome	5.17e-05	0.000401	CcSEcCtD
Darifenacin—Nausea—Vigabatrin—epilepsy syndrome	5.16e-05	0.000401	CcSEcCtD
Darifenacin—Vomiting—Zonisamide—epilepsy syndrome	5.16e-05	0.0004	CcSEcCtD
Darifenacin—Insomnia—Valproic Acid—epilepsy syndrome	5.15e-05	0.0004	CcSEcCtD
Darifenacin—Oedema—Pregabalin—epilepsy syndrome	5.15e-05	0.000399	CcSEcCtD
Darifenacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.15e-05	0.000399	CcSEcCtD
Darifenacin—Asthenia—Lamotrigine—epilepsy syndrome	5.14e-05	0.000399	CcSEcCtD
Darifenacin—Dizziness—Phenytoin—epilepsy syndrome	5.13e-05	0.000398	CcSEcCtD
Darifenacin—Rash—Zonisamide—epilepsy syndrome	5.11e-05	0.000397	CcSEcCtD
Darifenacin—Infection—Pregabalin—epilepsy syndrome	5.11e-05	0.000397	CcSEcCtD
Darifenacin—Palpitations—Gabapentin—epilepsy syndrome	5.11e-05	0.000397	CcSEcCtD
Darifenacin—Dermatitis—Zonisamide—epilepsy syndrome	5.11e-05	0.000397	CcSEcCtD
Darifenacin—Dizziness—Oxcarbazepine—epilepsy syndrome	5.11e-05	0.000396	CcSEcCtD
Darifenacin—Nausea—Diazepam—epilepsy syndrome	5.08e-05	0.000395	CcSEcCtD
Darifenacin—Loss of consciousness—Gabapentin—epilepsy syndrome	5.08e-05	0.000394	CcSEcCtD
Darifenacin—Headache—Zonisamide—epilepsy syndrome	5.08e-05	0.000394	CcSEcCtD
Darifenacin—Dyspnoea—Valproic Acid—epilepsy syndrome	5.07e-05	0.000394	CcSEcCtD
Darifenacin—Diarrhoea—Carbamazepine—epilepsy syndrome	5.07e-05	0.000394	CcSEcCtD
Darifenacin—Angiopathy—Topiramate—epilepsy syndrome	5.07e-05	0.000393	CcSEcCtD
Darifenacin—Pruritus—Lamotrigine—epilepsy syndrome	5.07e-05	0.000393	CcSEcCtD
Darifenacin—Shock—Pregabalin—epilepsy syndrome	5.06e-05	0.000393	CcSEcCtD
Darifenacin—Somnolence—Valproic Acid—epilepsy syndrome	5.06e-05	0.000393	CcSEcCtD
Darifenacin—Nervous system disorder—Pregabalin—epilepsy syndrome	5.05e-05	0.000392	CcSEcCtD
Darifenacin—Cough—Gabapentin—epilepsy syndrome	5.04e-05	0.000392	CcSEcCtD
Darifenacin—Mediastinal disorder—Topiramate—epilepsy syndrome	5.04e-05	0.000391	CcSEcCtD
Darifenacin—Methadone—OPRD1—epilepsy syndrome	5.03e-05	0.0117	CrCbGaD
Darifenacin—Tachycardia—Pregabalin—epilepsy syndrome	5.02e-05	0.00039	CcSEcCtD
Darifenacin—Dyspepsia—Valproic Acid—epilepsy syndrome	5.01e-05	0.000389	CcSEcCtD
Darifenacin—Skin disorder—Pregabalin—epilepsy syndrome	5e-05	0.000388	CcSEcCtD
Darifenacin—Hypertension—Gabapentin—epilepsy syndrome	4.99e-05	0.000387	CcSEcCtD
Darifenacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.97e-05	0.000386	CcSEcCtD
Darifenacin—Vomiting—Clonazepam—epilepsy syndrome	4.97e-05	0.000386	CcSEcCtD
Darifenacin—Vomiting—Phenytoin—epilepsy syndrome	4.94e-05	0.000383	CcSEcCtD
Darifenacin—Clotrimazole—ABCC2—epilepsy syndrome	4.93e-05	0.0114	CrCbGaD
Darifenacin—Rash—Clonazepam—epilepsy syndrome	4.93e-05	0.000382	CcSEcCtD
Darifenacin—Dermatitis—Clonazepam—epilepsy syndrome	4.92e-05	0.000382	CcSEcCtD
Darifenacin—Arthralgia—Gabapentin—epilepsy syndrome	4.92e-05	0.000382	CcSEcCtD
Darifenacin—Nausea—Felbamate—epilepsy syndrome	4.92e-05	0.000382	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.91e-05	0.000381	CcSEcCtD
Darifenacin—Vomiting—Oxcarbazepine—epilepsy syndrome	4.91e-05	0.000381	CcSEcCtD
Darifenacin—Dizziness—Carbamazepine—epilepsy syndrome	4.9e-05	0.00038	CcSEcCtD
Darifenacin—Diarrhoea—Lamotrigine—epilepsy syndrome	4.9e-05	0.00038	CcSEcCtD
Darifenacin—Headache—Clonazepam—epilepsy syndrome	4.9e-05	0.00038	CcSEcCtD
Darifenacin—Rash—Phenytoin—epilepsy syndrome	4.9e-05	0.00038	CcSEcCtD
Darifenacin—Mental disorder—Topiramate—epilepsy syndrome	4.89e-05	0.00038	CcSEcCtD
Darifenacin—Dermatitis—Phenytoin—epilepsy syndrome	4.89e-05	0.00038	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.89e-05	0.000379	CcSEcCtD
Darifenacin—Rash—Oxcarbazepine—epilepsy syndrome	4.87e-05	0.000378	CcSEcCtD
Darifenacin—Constipation—Valproic Acid—epilepsy syndrome	4.87e-05	0.000378	CcSEcCtD
Darifenacin—Pain—Valproic Acid—epilepsy syndrome	4.87e-05	0.000378	CcSEcCtD
Darifenacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.86e-05	0.000378	CcSEcCtD
Darifenacin—Headache—Phenytoin—epilepsy syndrome	4.86e-05	0.000377	CcSEcCtD
Darifenacin—Headache—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000375	CcSEcCtD
Darifenacin—Nausea—Zonisamide—epilepsy syndrome	4.82e-05	0.000374	CcSEcCtD
Darifenacin—Dry mouth—Gabapentin—epilepsy syndrome	4.81e-05	0.000374	CcSEcCtD
Darifenacin—Flatulence—Topiramate—epilepsy syndrome	4.79e-05	0.000372	CcSEcCtD
Darifenacin—Dysgeusia—Topiramate—epilepsy syndrome	4.76e-05	0.00037	CcSEcCtD
Darifenacin—Confusional state—Gabapentin—epilepsy syndrome	4.76e-05	0.000369	CcSEcCtD
Darifenacin—Dizziness—Lamotrigine—epilepsy syndrome	4.74e-05	0.000368	CcSEcCtD
Darifenacin—Oedema—Gabapentin—epilepsy syndrome	4.72e-05	0.000366	CcSEcCtD
Darifenacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.72e-05	0.000366	CcSEcCtD
Darifenacin—Vomiting—Carbamazepine—epilepsy syndrome	4.71e-05	0.000366	CcSEcCtD
Darifenacin—Back pain—Topiramate—epilepsy syndrome	4.7e-05	0.000365	CcSEcCtD
Darifenacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.69e-05	0.000364	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.69e-05	0.000364	CcSEcCtD
Darifenacin—Infection—Gabapentin—epilepsy syndrome	4.69e-05	0.000364	CcSEcCtD
Darifenacin—Rash—Carbamazepine—epilepsy syndrome	4.67e-05	0.000363	CcSEcCtD
Darifenacin—Dermatitis—Carbamazepine—epilepsy syndrome	4.67e-05	0.000362	CcSEcCtD
Darifenacin—Trospium—CYP2D6—epilepsy syndrome	4.66e-05	0.0108	CrCbGaD
Darifenacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.65e-05	0.000361	CcSEcCtD
Darifenacin—Insomnia—Pregabalin—epilepsy syndrome	4.65e-05	0.000361	CcSEcCtD
Darifenacin—Nausea—Clonazepam—epilepsy syndrome	4.64e-05	0.00036	CcSEcCtD
Darifenacin—Headache—Carbamazepine—epilepsy syndrome	4.64e-05	0.00036	CcSEcCtD
Darifenacin—Shock—Gabapentin—epilepsy syndrome	4.64e-05	0.00036	CcSEcCtD
Darifenacin—Nervous system disorder—Gabapentin—epilepsy syndrome	4.63e-05	0.000359	CcSEcCtD
Darifenacin—Nausea—Phenytoin—epilepsy syndrome	4.61e-05	0.000358	CcSEcCtD
Darifenacin—Tachycardia—Gabapentin—epilepsy syndrome	4.6e-05	0.000357	CcSEcCtD
Darifenacin—Dyspnoea—Pregabalin—epilepsy syndrome	4.59e-05	0.000356	CcSEcCtD
Darifenacin—Nausea—Oxcarbazepine—epilepsy syndrome	4.59e-05	0.000356	CcSEcCtD
Darifenacin—Vision blurred—Topiramate—epilepsy syndrome	4.58e-05	0.000356	CcSEcCtD
Darifenacin—Skin disorder—Gabapentin—epilepsy syndrome	4.58e-05	0.000356	CcSEcCtD
Darifenacin—Somnolence—Pregabalin—epilepsy syndrome	4.57e-05	0.000355	CcSEcCtD
Darifenacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.56e-05	0.000354	CcSEcCtD
Darifenacin—Vomiting—Lamotrigine—epilepsy syndrome	4.55e-05	0.000353	CcSEcCtD
Darifenacin—Rash—Lamotrigine—epilepsy syndrome	4.52e-05	0.00035	CcSEcCtD
Darifenacin—Dermatitis—Lamotrigine—epilepsy syndrome	4.51e-05	0.00035	CcSEcCtD
Darifenacin—Abdominal pain—Valproic Acid—epilepsy syndrome	4.5e-05	0.000349	CcSEcCtD
Darifenacin—Headache—Lamotrigine—epilepsy syndrome	4.49e-05	0.000348	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.44e-05	0.000345	CcSEcCtD
Darifenacin—Nausea—Carbamazepine—epilepsy syndrome	4.4e-05	0.000342	CcSEcCtD
Darifenacin—Pain—Pregabalin—epilepsy syndrome	4.4e-05	0.000341	CcSEcCtD
Darifenacin—Constipation—Pregabalin—epilepsy syndrome	4.4e-05	0.000341	CcSEcCtD
Darifenacin—Syncope—Topiramate—epilepsy syndrome	4.36e-05	0.000339	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.3e-05	0.000334	CcSEcCtD
Darifenacin—Palpitations—Topiramate—epilepsy syndrome	4.3e-05	0.000334	CcSEcCtD
Darifenacin—Loss of consciousness—Topiramate—epilepsy syndrome	4.27e-05	0.000332	CcSEcCtD
Darifenacin—Insomnia—Gabapentin—epilepsy syndrome	4.27e-05	0.000331	CcSEcCtD
Darifenacin—Nausea—Lamotrigine—epilepsy syndrome	4.25e-05	0.00033	CcSEcCtD
Darifenacin—Cough—Topiramate—epilepsy syndrome	4.24e-05	0.000329	CcSEcCtD
Darifenacin—Feeling abnormal—Pregabalin—epilepsy syndrome	4.24e-05	0.000329	CcSEcCtD
Darifenacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.21e-05	0.000327	CcSEcCtD
Darifenacin—Dyspnoea—Gabapentin—epilepsy syndrome	4.21e-05	0.000326	CcSEcCtD
Darifenacin—Hypertension—Topiramate—epilepsy syndrome	4.2e-05	0.000326	CcSEcCtD
Darifenacin—Somnolence—Gabapentin—epilepsy syndrome	4.19e-05	0.000326	CcSEcCtD
Darifenacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.19e-05	0.000325	CcSEcCtD
Darifenacin—Dyspepsia—Gabapentin—epilepsy syndrome	4.15e-05	0.000322	CcSEcCtD
Darifenacin—Arthralgia—Topiramate—epilepsy syndrome	4.14e-05	0.000321	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.11e-05	0.000319	CcSEcCtD
Darifenacin—Asthenia—Valproic Acid—epilepsy syndrome	4.08e-05	0.000317	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.07e-05	0.000316	CcSEcCtD
Darifenacin—Abdominal pain—Pregabalin—epilepsy syndrome	4.07e-05	0.000316	CcSEcCtD
Darifenacin—Dry mouth—Topiramate—epilepsy syndrome	4.05e-05	0.000314	CcSEcCtD
Darifenacin—Pain—Gabapentin—epilepsy syndrome	4.03e-05	0.000313	CcSEcCtD
Darifenacin—Constipation—Gabapentin—epilepsy syndrome	4.03e-05	0.000313	CcSEcCtD
Darifenacin—Pruritus—Valproic Acid—epilepsy syndrome	4.03e-05	0.000313	CcSEcCtD
Darifenacin—Confusional state—Topiramate—epilepsy syndrome	4e-05	0.000311	CcSEcCtD
Darifenacin—Oedema—Topiramate—epilepsy syndrome	3.97e-05	0.000308	CcSEcCtD
Darifenacin—Infection—Topiramate—epilepsy syndrome	3.94e-05	0.000306	CcSEcCtD
Darifenacin—Shock—Topiramate—epilepsy syndrome	3.91e-05	0.000303	CcSEcCtD
Darifenacin—Diarrhoea—Valproic Acid—epilepsy syndrome	3.89e-05	0.000302	CcSEcCtD
Darifenacin—Nervous system disorder—Topiramate—epilepsy syndrome	3.89e-05	0.000302	CcSEcCtD
Darifenacin—Feeling abnormal—Gabapentin—epilepsy syndrome	3.89e-05	0.000302	CcSEcCtD
Darifenacin—Tachycardia—Topiramate—epilepsy syndrome	3.87e-05	0.000301	CcSEcCtD
Darifenacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.86e-05	0.000299	CcSEcCtD
Darifenacin—Skin disorder—Topiramate—epilepsy syndrome	3.86e-05	0.000299	CcSEcCtD
Darifenacin—Methadone—OPRM1—epilepsy syndrome	3.85e-05	0.00892	CrCbGaD
Darifenacin—Hyperhidrosis—Topiramate—epilepsy syndrome	3.84e-05	0.000298	CcSEcCtD
Darifenacin—Hypersensitivity—Pregabalin—epilepsy syndrome	3.79e-05	0.000294	CcSEcCtD
Darifenacin—Dizziness—Valproic Acid—epilepsy syndrome	3.76e-05	0.000292	CcSEcCtD
Darifenacin—Abdominal pain—Gabapentin—epilepsy syndrome	3.73e-05	0.000289	CcSEcCtD
Darifenacin—Asthenia—Pregabalin—epilepsy syndrome	3.69e-05	0.000287	CcSEcCtD
Darifenacin—Pruritus—Pregabalin—epilepsy syndrome	3.64e-05	0.000283	CcSEcCtD
Darifenacin—Vomiting—Valproic Acid—epilepsy syndrome	3.62e-05	0.000281	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.62e-05	0.000281	CcSEcCtD
Darifenacin—Insomnia—Topiramate—epilepsy syndrome	3.59e-05	0.000279	CcSEcCtD
Darifenacin—Rash—Valproic Acid—epilepsy syndrome	3.59e-05	0.000279	CcSEcCtD
Darifenacin—Dermatitis—Valproic Acid—epilepsy syndrome	3.59e-05	0.000278	CcSEcCtD
Darifenacin—Headache—Valproic Acid—epilepsy syndrome	3.57e-05	0.000277	CcSEcCtD
Darifenacin—Dyspnoea—Topiramate—epilepsy syndrome	3.54e-05	0.000275	CcSEcCtD
Darifenacin—Somnolence—Topiramate—epilepsy syndrome	3.53e-05	0.000274	CcSEcCtD
Darifenacin—Diarrhoea—Pregabalin—epilepsy syndrome	3.52e-05	0.000273	CcSEcCtD
Darifenacin—Dyspepsia—Topiramate—epilepsy syndrome	3.49e-05	0.000271	CcSEcCtD
Darifenacin—Hypersensitivity—Gabapentin—epilepsy syndrome	3.48e-05	0.00027	CcSEcCtD
Darifenacin—Clotrimazole—CYP2C19—epilepsy syndrome	3.43e-05	0.00795	CrCbGaD
Darifenacin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.43e-05	0.000266	CcSEcCtD
Darifenacin—Dizziness—Pregabalin—epilepsy syndrome	3.4e-05	0.000264	CcSEcCtD
Darifenacin—Constipation—Topiramate—epilepsy syndrome	3.39e-05	0.000263	CcSEcCtD
Darifenacin—Pain—Topiramate—epilepsy syndrome	3.39e-05	0.000263	CcSEcCtD
Darifenacin—Asthenia—Gabapentin—epilepsy syndrome	3.39e-05	0.000263	CcSEcCtD
Darifenacin—Nausea—Valproic Acid—epilepsy syndrome	3.38e-05	0.000262	CcSEcCtD
Darifenacin—Pruritus—Gabapentin—epilepsy syndrome	3.34e-05	0.000259	CcSEcCtD
Darifenacin—Fexofenadine—CYP2D6—epilepsy syndrome	3.29e-05	0.00763	CrCbGaD
Darifenacin—Vomiting—Pregabalin—epilepsy syndrome	3.27e-05	0.000254	CcSEcCtD
Darifenacin—Feeling abnormal—Topiramate—epilepsy syndrome	3.27e-05	0.000254	CcSEcCtD
Darifenacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.25e-05	0.000252	CcSEcCtD
Darifenacin—Rash—Pregabalin—epilepsy syndrome	3.24e-05	0.000252	CcSEcCtD
Darifenacin—Dermatitis—Pregabalin—epilepsy syndrome	3.24e-05	0.000252	CcSEcCtD
Darifenacin—Diarrhoea—Gabapentin—epilepsy syndrome	3.23e-05	0.000251	CcSEcCtD
Darifenacin—Headache—Pregabalin—epilepsy syndrome	3.22e-05	0.00025	CcSEcCtD
Darifenacin—Abdominal pain—Topiramate—epilepsy syndrome	3.14e-05	0.000244	CcSEcCtD
Darifenacin—Dizziness—Gabapentin—epilepsy syndrome	3.12e-05	0.000242	CcSEcCtD
Darifenacin—Nausea—Pregabalin—epilepsy syndrome	3.06e-05	0.000237	CcSEcCtD
Darifenacin—Vomiting—Gabapentin—epilepsy syndrome	3e-05	0.000233	CcSEcCtD
Darifenacin—Rash—Gabapentin—epilepsy syndrome	2.97e-05	0.000231	CcSEcCtD
Darifenacin—Dermatitis—Gabapentin—epilepsy syndrome	2.97e-05	0.000231	CcSEcCtD
Darifenacin—Headache—Gabapentin—epilepsy syndrome	2.96e-05	0.000229	CcSEcCtD
Darifenacin—Hypersensitivity—Topiramate—epilepsy syndrome	2.92e-05	0.000227	CcSEcCtD
Darifenacin—Asthenia—Topiramate—epilepsy syndrome	2.85e-05	0.000221	CcSEcCtD
Darifenacin—Pruritus—Topiramate—epilepsy syndrome	2.81e-05	0.000218	CcSEcCtD
Darifenacin—Nausea—Gabapentin—epilepsy syndrome	2.8e-05	0.000218	CcSEcCtD
Darifenacin—Diarrhoea—Topiramate—epilepsy syndrome	2.72e-05	0.000211	CcSEcCtD
Darifenacin—Dizziness—Topiramate—epilepsy syndrome	2.62e-05	0.000204	CcSEcCtD
Darifenacin—Clotrimazole—CYP2D6—epilepsy syndrome	2.54e-05	0.00589	CrCbGaD
Darifenacin—Vomiting—Topiramate—epilepsy syndrome	2.52e-05	0.000196	CcSEcCtD
Darifenacin—Rash—Topiramate—epilepsy syndrome	2.5e-05	0.000194	CcSEcCtD
Darifenacin—Dermatitis—Topiramate—epilepsy syndrome	2.5e-05	0.000194	CcSEcCtD
Darifenacin—Headache—Topiramate—epilepsy syndrome	2.49e-05	0.000193	CcSEcCtD
Darifenacin—Nausea—Topiramate—epilepsy syndrome	2.36e-05	0.000183	CcSEcCtD
Darifenacin—Fexofenadine—ABCB1—epilepsy syndrome	2.35e-05	0.00545	CrCbGaD
Darifenacin—Loperamide—CYP2D6—epilepsy syndrome	2.09e-05	0.00485	CrCbGaD
Darifenacin—Methadone—CYP2C19—epilepsy syndrome	2.01e-05	0.00466	CrCbGaD
Darifenacin—Clotrimazole—ABCB1—epilepsy syndrome	1.82e-05	0.00421	CrCbGaD
Darifenacin—Fentanyl—ABCB1—epilepsy syndrome	1.55e-05	0.0036	CrCbGaD
Darifenacin—Loperamide—ABCB1—epilepsy syndrome	1.49e-05	0.00347	CrCbGaD
Darifenacin—Methadone—CYP2D6—epilepsy syndrome	1.49e-05	0.00345	CrCbGaD
Darifenacin—Methadone—ABCB1—epilepsy syndrome	1.06e-05	0.00247	CrCbGaD
Darifenacin—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	4.24e-06	6.53e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	4.23e-06	6.52e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	4.22e-06	6.51e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.21e-06	6.5e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.2e-06	6.48e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	4.2e-06	6.48e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	4.19e-06	6.46e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	4.19e-06	6.45e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	4.17e-06	6.43e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.15e-06	6.4e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.13e-06	6.37e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	4.11e-06	6.33e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.1e-06	6.32e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	4.09e-06	6.3e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	4.04e-06	6.23e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.04e-06	6.23e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.04e-06	6.23e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.03e-06	6.22e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	4.03e-06	6.21e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	4.03e-06	6.21e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.02e-06	6.2e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.02e-06	6.2e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	4.02e-06	6.19e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.01e-06	6.18e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4e-06	6.17e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4e-06	6.16e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4e-06	6.16e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	3.99e-06	6.15e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	3.99e-06	6.15e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	3.99e-06	6.15e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	3.98e-06	6.14e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.97e-06	6.12e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	3.96e-06	6.11e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	3.96e-06	6.11e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.95e-06	6.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	3.95e-06	6.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	3.95e-06	6.09e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	3.95e-06	6.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	3.94e-06	6.07e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	3.93e-06	6.06e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—HMOX1—epilepsy syndrome	3.92e-06	6.04e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	3.91e-06	6.03e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	3.91e-06	6.03e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	3.9e-06	6.01e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	3.87e-06	5.96e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAT—epilepsy syndrome	3.86e-06	5.96e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	3.86e-06	5.94e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	3.85e-06	5.93e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	3.82e-06	5.89e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	3.82e-06	5.88e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	3.81e-06	5.88e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.81e-06	5.88e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.81e-06	5.88e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCB1—epilepsy syndrome	3.76e-06	5.8e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	3.75e-06	5.79e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	3.74e-06	5.77e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	3.74e-06	5.76e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.73e-06	5.75e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	3.71e-06	5.71e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	3.69e-06	5.68e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	3.67e-06	5.66e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	3.66e-06	5.65e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	3.66e-06	5.64e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	3.66e-06	5.64e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.65e-06	5.63e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	3.65e-06	5.63e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	3.65e-06	5.63e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	3.64e-06	5.61e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	3.62e-06	5.57e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.6e-06	5.55e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	3.6e-06	5.55e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	3.59e-06	5.53e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	3.58e-06	5.52e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.58e-06	5.52e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	3.58e-06	5.51e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	3.57e-06	5.51e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.55e-06	5.48e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.54e-06	5.45e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	3.52e-06	5.43e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.52e-06	5.42e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.51e-06	5.41e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	3.51e-06	5.41e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	3.5e-06	5.4e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GPX1—epilepsy syndrome	3.49e-06	5.39e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.49e-06	5.38e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	3.4e-06	5.25e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	3.39e-06	5.23e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	3.37e-06	5.2e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.37e-06	5.2e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.36e-06	5.18e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.36e-06	5.18e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	3.36e-06	5.18e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	3.36e-06	5.18e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	3.35e-06	5.17e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.33e-06	5.13e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.32e-06	5.12e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.29e-06	5.07e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.26e-06	5.02e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.25e-06	5e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.21e-06	4.95e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	3.21e-06	4.95e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.19e-06	4.92e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	3.14e-06	4.84e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.08e-06	4.75e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	3.07e-06	4.74e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.07e-06	4.73e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AGT—epilepsy syndrome	3.06e-06	4.72e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.04e-06	4.69e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.01e-06	4.64e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOE—epilepsy syndrome	3e-06	4.63e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3e-06	4.62e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	2.99e-06	4.62e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	2.98e-06	4.6e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.98e-06	4.6e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.98e-06	4.6e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.98e-06	4.59e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	2.97e-06	4.58e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	2.97e-06	4.58e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	2.96e-06	4.56e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	2.94e-06	4.54e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	2.94e-06	4.53e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.89e-06	4.45e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.89e-06	4.45e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.88e-06	4.44e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	2.87e-06	4.42e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.85e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	2.85e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.84e-06	4.38e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	2.84e-06	4.37e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	2.84e-06	4.37e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.82e-06	4.34e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	2.81e-06	4.33e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TH—epilepsy syndrome	2.81e-06	4.33e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.77e-06	4.27e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	2.76e-06	4.25e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	2.73e-06	4.21e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	2.72e-06	4.19e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.71e-06	4.18e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	2.7e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.67e-06	4.12e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	2.63e-06	4.06e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	2.58e-06	3.98e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—epilepsy syndrome	2.58e-06	3.98e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-06	3.97e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	2.57e-06	3.96e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-06	3.96e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	2.56e-06	3.95e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.54e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.54e-06	3.91e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	2.52e-06	3.89e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.52e-06	3.88e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.51e-06	3.87e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.49e-06	3.83e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.47e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.47e-06	3.8e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.46e-06	3.79e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.44e-06	3.76e-05	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	2.4e-06	3.7e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	2.38e-06	3.66e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.38e-06	3.66e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.37e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.35e-06	3.63e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—epilepsy syndrome	2.35e-06	3.63e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.34e-06	3.61e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.34e-06	3.61e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.34e-06	3.6e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.31e-06	3.56e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	2.31e-06	3.56e-05	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.3e-06	3.54e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.29e-06	3.54e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.28e-06	3.52e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.28e-06	3.51e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.25e-06	3.47e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-06	3.46e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.21e-06	3.41e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.18e-06	3.36e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.16e-06	3.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.16e-06	3.33e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.15e-06	3.31e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.14e-06	3.29e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.12e-06	3.26e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.11e-06	3.25e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.09e-06	3.22e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.09e-06	3.22e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.09e-06	3.21e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.07e-06	3.19e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.06e-06	3.17e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.06e-06	3.17e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-06	3.11e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	1.98e-06	3.06e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.96e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.95e-06	3.01e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	1.93e-06	2.98e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	2.95e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	2.94e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.89e-06	2.91e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.86e-06	2.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.84e-06	2.84e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.83e-06	2.83e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.83e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.8e-06	2.77e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	2.74e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1.77e-06	2.73e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.75e-06	2.7e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	2.69e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	2.68e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.72e-06	2.65e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.62e-06	2.49e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.61e-06	2.48e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	2.47e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	2.46e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.6e-06	2.46e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.58e-06	2.44e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	2.4e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.55e-06	2.39e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.54e-06	2.38e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.54e-06	2.37e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.53e-06	2.36e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	2.33e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.51e-06	2.33e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	2.33e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.49e-06	2.3e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.47e-06	2.27e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	2.26e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-06	2.26e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.45e-06	2.23e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.41e-06	2.17e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	2.15e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.39e-06	2.14e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.38e-06	2.12e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.37e-06	2.11e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	2.1e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	2.09e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.34e-06	2.07e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-06	1.98e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.23e-06	1.9e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	1.9e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.2e-06	1.85e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.17e-06	1.81e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.03e-06	1.59e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.01e-06	1.55e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.19e-07	1.42e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	8.67e-07	1.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	8.65e-07	1.33e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	8.56e-07	1.32e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.04e-07	1.24e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.18e-07	9.53e-06	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.04e-07	6.23e-06	CbGpPWpGaD
